Regdanvimab

Biorbyt

Regdanvimab

10

Research Use Only

Monoclonal

Unconjugated

Regdanvimab (CT-P59) is a human monoclonal antibody that targets the receptor-binding domain of SARS-CoV-2 spike protein, blocking interaction with ACE2 for viral entry. Regdanvimab can be used for the research of COVID-19.

-20°C,2°C to 8°C

12352203